Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,150 public trials 2,021 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
View Trial Details
Recruiting

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

NCT04643366

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Virginia Cancer Institute Richmond, Virginia, United States
  • Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States
  • VCU Community Memorial Healthcenter South Hill, Virginia, United States
  • VCU Health Tappahannock Hospital Tappahannock, Virginia, United States
View Trial Details
Recruiting

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

NCT06428409

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
Locations
  • UCLA ( Site 0317) Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus ( Site 0299) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0325) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0326) Aurora, Colorado, United States
View all 55 locations
View Trial Details
Recruiting

EXoPERT EMERALD Clinical Study

NCT07186296

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +37 more
Locations
  • Tibor Rubin VA Medical Center Long Beach, California, United States
  • City of Hope Duarte Cancer Center Los Angeles, California, United States
  • University of Hawaii Cancer Center Honolulu, Hawaii, United States
  • Lexington VA Healthcare System Lexington, Kentucky, United States
View Trial Details
Recruiting

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

NCT07552402

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma, +6 more
Locations
  • The Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
  • Baotou Cancer Hospital Baotou, Inner Mongolia, China
  • The Second Hospital of Dalian Medical University Dalian, Liaoning, China
View Trial Details
Recruiting

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

NCT07595874

Conditions
Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma, +23 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Seacliff Huntington Beach, California, United States
View Trial Details
Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

NCT07079631

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Yale University New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 14 locations
View Trial Details

Related conditions